Related Posts with Thumbnails

Saturday, February 09, 2019

Laminitis Research Videos: Advances in endocrinopathic laminitis diagnosis, treatment and science


Last week,  31 laminitis research articles, collected from recent editions of the prestigious Equine Veterinary Journal, were made freely available to the public. All 31 articles may be read and downloaded without charge for the next year.

What could make this better? A summary--or three of them, in fact. Today we offer an overview of the research, in the form of three short, concise videos by three of the authors. Each provides an overview of the articles in his or her area of research.



Nick Bamford: Laminitis Treatment


Nick Bamford, BVSc(Hons), PhD, DACVIM of the vet school at the University of Melbourne reviews evidence-based studies of treatment for endocrinopathic laminitis, including cryotherapy. At the top of his list is the importance of productive working relationships between veterinarians and farriers.

He mentions one of the articles which suggests that it might be beneficial to modify the role of farriers so they might play a larger role in early recognition of the disease; the paper discusses the two ways that farriers surveyed approach their work for a client, as well as the two ways that the clients surveyed perceive their working relationship with their farriers.

He also covers the study from the University of Utrecht in The Netherlands, which used Imprint moldable thermoplastic heart bar shoes on two groups of ponies--one group was obese, one was not--and documented improved movement in the obese group while wearing the shoes.

Early studies of pain medication (tramadol) and the soluble epoxide hydrolase inhibitor researched by Alonso Guedes at the University of Minnesota are covered as well.

Two articles in the collection cover methods of applying digital cryotherapy (immersive icing) as an intervention method.

In conclusion, Bamford looks to the future, and the experimental work done at Penn Vet with a novel approach to deliver gene therapy via regional limb perfusion directly to the tissue of the hoof to prevent support limb laminitis in the horse's "good" foot.

Nicola Menzies-Gow: Laminitis Diagnosis


Nicola Menzies-Gow, MA, VetMB, PhD, DipECEIM, Cert EM (int med), MRCVS is Reader in Equine Medicine at the Royal Veterinary College in England. She focused on the papers in the collection that are concerned with the all-important diagnosis of underlying endocrine conditions in the horse that may lead to laminitis, such as Equine Metabolic Syndrome and Pituitary Pars Intermedia Dysfunction, and the role of insulin dysregulation.

She begins with the shocking finding that 45 percent of cases of laminitis diagnosed by veterinarians were not recognized as laminitis by their owners. Menzies-Gow reviews progress in comparing the tests for insulin resistance, and the recent finetuning of the Oral Sugar Test, which uses common sugar syrup to trigger an insulin response. She also mentions research documenting the dip in the hormone leptin.

Finally, she covers the two tests available to measure Adrenocorticotropic hormone (ACTH), and the effects of season on the test results, which can be used to determine PPID or Equine Cushings Disease in horses.

Melody De Laat: Does research have a foothold?


Melody Dr Laat, BVSc (Hons), PhD, MANZCVS, Grad Cert HE, FHEA is Senior Lecturer at Queensland University of Technology in Australia. Her research covers the mechanism of insulin in laminitis, so she was perfectly suited to summarize that aspect of this special collection of articles. While Nicola had covered the important of determining insulin dysfunction's role in laminitis, Melody is immersed in how exactly insulin can cause laminitis within the horse's foot--where no insulin receptors are present.

She pointed to research articles in the collection that determined that while many horses with Equine Metabolic Syndrome are obese, not all obese horses are insulin resistant or at high risk for laminitis. Conversely, thin horses can have hyperinsulinemia and be at risk for laminitis.

Much of De Laat's research in the past has focused on the damage to the lamellar tissue in the foot by laminitis. Her studies led to research into the possible that insulin somehow impacts Insulin Growth Factor-1 (IGF-1) receptors, which are found in the foot, and the possibility that hybrid IGF-1 receptors are involved.

De Laat sounds optimistic for the future of her research, but listeners might take note of her prediction that perhaps ten years from now researchers will actually understand laminitis, and that when that happens, work on a treatment might begin.

• • • • •

Click here to access the index page of the collection on the web to bookmark for reference.



© Fran Jurga and Hoofcare Publishing; Fran Jurga's Hoof Blog is the news service for Hoofcare and Lameness Publishing. Please, no re-use of text or images on other sites or social media without permission--please link instead. (Please ask if you need help.) The Hoof Blog may be read online at the blog page, checked via RSS feed, or received via a headlines-link email (requires signup in box at top right of blog page). Use the little envelope symbol below to email this article to others. The "translator" tool in the right sidebar will convert this article (roughly) to the language of your choice. To share this article on Facebook and other social media, click on the small symbols below the labels. Be sure to "like" the Hoofcare and Lameness Facebook page and click on "get notifications" under the page's "like" button to keep up with the hoof news on Facebook. Questions or problems with the Hoof Blog? Click here to send an email hoofblog@gmail.com.  


Follow Hoofcare + Lameness on Twitter: @HoofBlog
Read this blog's headlines on the Hoofcare + Lameness Facebook Page
 
Disclosure of Material Connection: The Hoof Blog (Hoofcare Publishing) has not received any direct compensation for writing this post. Hoofcare Publishing has no material connection to the brands, products, or services mentioned, other than products and services of Hoofcare Publishing. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: Guides Concerning the Use of Endorsements and Testimonials in Advertising.

No comments: